MedPath

Hypolipidemic and Antioxidant Capacity of Spirulina and Exercise

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Interventions
Dietary Supplement: Supplementation with Spirulina maxima
Other: Washout
Other: Supplementation with placebo
Other: Isoenergetic diet
Other: Exercise program
Registration Number
NCT02837666
Lead Sponsor
Universidad Autonoma de Ciudad Juarez
Brief Summary

The purpose of this study is to demonstrate that Spirulina maxima intake and a dosed physical activity program will decrease, both independently and synergistically, cardiovascular risks (Dyslipidemias and oxidative stress) in overweight and obese subjects.

Detailed Description

Cardiovascular diseases are the leading cause of death globally, being dyslipidemias, oxidative stress, sedentary lifestyle and obesity primary risk factors. As a way to reduce cardiovascular diseases risk factors, the intake of antioxidants that come from a fruit and vegetable-rich diet or nutritional supplements, have been proposed; in this sense, the cyanobacterium Spirulina maxima is an important source of antioxidants, which is currently associated with cardiovascular protection properties. Furthermore, physical exercise at moderated intensity has protective effect exerted against cardiovascular diseases risks, mainly due to physiological adaptations, including expression of antioxidant enzymes, which stop formation and propagation of radicals, improving redox status of the organism.

There is evidence that Spirulina maxima, in addition to exercise, decreases cardiovascular diseases risks, this was mainly observed in animal models. However, no studies in humans under Spirulina maxima and exercise experimental designs proving these benefits are reported. Therefore this study will analyze the independent and synergistic effect of the intake of Spirulina maxima with a program of physical exercise at moderated intensity on general fitness, plasma lipid profile and antioxidant capacity in overweight and obese subjects.

Methods/design: Through a randomized, double blind, placebo controlled, counterbalanced crossover study design, 80 healthy overweight and obese subjects will be assessed during a 12 week isoenergetic diet, accompanied by 4.5 g/day Spirulina maxima intake and/or a systematic physical exercise program at moderate intensity. Body composition, VO2 consumption, heart rate, blood lactate, plasma concentrations of triacylglycerols, total, low and high-density lipoprotein cholesterol, antioxidant status, lipid oxidation, protein carbonyls, superoxide dismutase, catalase, glutathione, glutathione peroxidase, glutathione reductase, and paraoxonase will be assessed.

Discussion: Spirulina maxima and exercise are good alternatives to improve general fitness, to prevent or lessen dyslipidemia and oxidative stress in subjects with risk factor of chronic or noncommunicable diseases. However the independent and synergistic effect of Spirulina maxima with exercise against dyslipidemias and stress in overweight and obesity is not yet known.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Overweight (Body mass index (BMI): 25-29.9 kg/m2) and obese (BMI: > 30 kg/m2) persons
Exclusion Criteria
  • Taking drugs and/or food or vitamin supplements
  • diabetes
  • have a physical or electrocardiographic injury that prevents them from engaging in regular physical exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
No exercise group and supplementationSupplementation with placeboSupplementation with Spirulina maxima Supplementation with placebo Group without exercise program and supplementation with Spirulina maxima or placebo (4.5 g/d) in capsules during 6 weeks, then a 2 weeks washout, to finally proceed to the other treatment during 6 more weeks. During the 14 weeks of study duration every participant will have a personal isoenergetic diet.
Exercise group and supplementationSupplementation with placeboSupplementation with Spirulina maxima Supplementation with placebo Group with exercise program and supplementation with Spirulina maxima or placebo (4.5 g/d) in capsules during 6 weeks, then a 2 weeks washout, to finally proceed to the other treatment during 6 more weeks. During the 14 weeks of study duration every participant will have a personal isoenergetic diet.
Exercise group and supplementationExercise programSupplementation with Spirulina maxima Supplementation with placebo Group with exercise program and supplementation with Spirulina maxima or placebo (4.5 g/d) in capsules during 6 weeks, then a 2 weeks washout, to finally proceed to the other treatment during 6 more weeks. During the 14 weeks of study duration every participant will have a personal isoenergetic diet.
Exercise group and supplementationSupplementation with Spirulina maximaSupplementation with Spirulina maxima Supplementation with placebo Group with exercise program and supplementation with Spirulina maxima or placebo (4.5 g/d) in capsules during 6 weeks, then a 2 weeks washout, to finally proceed to the other treatment during 6 more weeks. During the 14 weeks of study duration every participant will have a personal isoenergetic diet.
Exercise group and supplementationWashoutSupplementation with Spirulina maxima Supplementation with placebo Group with exercise program and supplementation with Spirulina maxima or placebo (4.5 g/d) in capsules during 6 weeks, then a 2 weeks washout, to finally proceed to the other treatment during 6 more weeks. During the 14 weeks of study duration every participant will have a personal isoenergetic diet.
Exercise group and supplementationIsoenergetic dietSupplementation with Spirulina maxima Supplementation with placebo Group with exercise program and supplementation with Spirulina maxima or placebo (4.5 g/d) in capsules during 6 weeks, then a 2 weeks washout, to finally proceed to the other treatment during 6 more weeks. During the 14 weeks of study duration every participant will have a personal isoenergetic diet.
No exercise group and supplementationSupplementation with Spirulina maximaSupplementation with Spirulina maxima Supplementation with placebo Group without exercise program and supplementation with Spirulina maxima or placebo (4.5 g/d) in capsules during 6 weeks, then a 2 weeks washout, to finally proceed to the other treatment during 6 more weeks. During the 14 weeks of study duration every participant will have a personal isoenergetic diet.
No exercise group and supplementationWashoutSupplementation with Spirulina maxima Supplementation with placebo Group without exercise program and supplementation with Spirulina maxima or placebo (4.5 g/d) in capsules during 6 weeks, then a 2 weeks washout, to finally proceed to the other treatment during 6 more weeks. During the 14 weeks of study duration every participant will have a personal isoenergetic diet.
No exercise group and supplementationIsoenergetic dietSupplementation with Spirulina maxima Supplementation with placebo Group without exercise program and supplementation with Spirulina maxima or placebo (4.5 g/d) in capsules during 6 weeks, then a 2 weeks washout, to finally proceed to the other treatment during 6 more weeks. During the 14 weeks of study duration every participant will have a personal isoenergetic diet.
Primary Outcome Measures
NameTimeMethod
Change in lipid profile14 weeks

Change in plasma triacylglycerols, total cholesterol, high density lipoproteins cholesterol, and low density lipoproteins cholesterol after each treatment by using standardized enzymatic methods

Secondary Outcome Measures
NameTimeMethod
Redox status assessed by change in glutathione14 weeks

Change in glutathione concentration by using standardized specific methods

Redox status assessed by change in glutathione reductase14 weeks

Change in glutathione reductase concentration by using standardized specific methods

General fitness assessed by change in maximum oxygen consumption14 weeks

Change in maximum oxygen consumption by using a gas analyzer (Cortex Metalizer 3B)

General fitness assessed by change in body mass14 weeks

Change in body fat mass and body lean mass by using pletysmography (BOD-POD)

General fitness assessed by change in heart rate14 weeks

Change in heart rate by using a pulsometer (Polar HT7)

General fitness assessed by change in lactate14 weeks

Change in lactate concentration by using an automatized method (YSI lactate analyzer-1600)

General fitness assessed by change in blood pressure14 weeks

Change in blood pressure by using an aneroid sphygmomanometer (Edimetric, Medical Technologies)

Redox status assessed by change in malondialdehyde14 weeks

Change in malondialdehyde concentration by using standardized specific methods

Redox status assessed by change in protein carbonyls14 weeks

Change in protein carbonyls concentration by using standardized specific methods

Redox status assessed by change in paraoxonase14 weeks

Change in paraoxonase concentration by using standardized specific methods

Redox status assessed by change in superoxide dismutase14 weeks

Change in superoxide dismutase concentration by using standardized specific methods

Redox status assessed by change in catalase14 weeks

Change in catalase concentration by using standardized specific methods

Redox status assessed by change in glutathione peroxidase14 weeks

Change in glutathione peroxidase concentration by using standardized specific methods

Trial Locations

Locations (1)

Universidad Autonoma de Ciudad Juarez

🇲🇽

Juarez, Chihuahua, Mexico

© Copyright 2025. All Rights Reserved by MedPath